Trial Profile
Effects of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on pharmacokinetics of donepezil in patients with dementia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia
- Focus Pharmacokinetics
- 11 Dec 2015 New trial record